Multi-Center Evaluation of Post-Operative Morbidity and Mortality after Optimal Cytoreductive Surgery for Advanced Ovarian Cancer

Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience

(2010) Michele Peiretti et al.   GYNECOLOGIC ONCOLOGY

Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer

(2010) Ignace Vergote et al.   NEW ENGLAND JOURNAL OF MEDICINE

Does Neoadjuvant Chemotherapy Increase Optimal Cytoreduction Rate in Advanced Ovarian Cancer? Meta-Analysis of 21 Studies

(2009) Sokbom Kang et al.   ANNALS OF SURGICAL ONCOLOGY

Pulmonary morbidity of diaphragmatic surgery for stage III/IV ovarian cancer

(2009) E Chéreau et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials

(2009) Andreas du Bois et al.   CANCER

Postoperative mortality after primary cytoreductive surgery for advanced stage epithelial ovarian cancer: A systematic review

(2009) Cornelis G. Gerestein et al.   GYNECOLOGIC ONCOLOGY